<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Coleção:</title>
  <link rel="alternate" href="https://repositoriobce.fepecs.edu.br/handle/123456789/1290" />
  <subtitle />
  <id>https://repositoriobce.fepecs.edu.br/handle/123456789/1290</id>
  <updated>2026-04-12T08:48:45Z</updated>
  <dc:date>2026-04-12T08:48:45Z</dc:date>
  <entry>
    <title>Perfil epidemiológico de pacientes com câncer de mama admitidas em serviço público de Brasília</title>
    <link rel="alternate" href="https://repositoriobce.fepecs.edu.br/handle/123456789/1292" />
    <author>
      <name>Britto, Carlos Henrique Melato Gois de</name>
    </author>
    <author>
      <name>Siqueira, Fábio</name>
    </author>
    <author>
      <name>Mascarenhas, Elisa Cançado Porto</name>
    </author>
    <id>https://repositoriobce.fepecs.edu.br/handle/123456789/1292</id>
    <updated>2024-09-10T06:00:20Z</updated>
    <published>2024-08-30T00:00:00Z</published>
    <summary type="text">Título: Perfil epidemiológico de pacientes com câncer de mama admitidas em serviço público de Brasília
Autor(es): Britto, Carlos Henrique Melato Gois de; Siqueira, Fábio; Mascarenhas, Elisa Cançado Porto
Abstract: Introduction: breast cancer is the most diagnosed malignancy in the world. With particularities related to age and staging, Brazilian women are at greater risk of being diagnosed with an advanced disease. The Ministry of Health of Brazil usually recommends screening for the age group from 50 to 69 years old, with the aim of detecting early stages of the disease. It is important to correlate local numbers with screening efforts and age at diagnosis. Endpoints: correlate age at diagnosis with literature data, histological subtypes and epidemiological profile of patients treated. Methods: cross-sectional, analytical, retrospective study through analysis of medical records of patients with breast cancer treated in a public hospital in Brasília between 2015 and 2019. Results: 782 medical records were evaluated. Age ranged from 27 to 86 years, with 40% under 50 and 60% aged 50 or over. The most common stages were II and III (35% each). 37% were variants with a poor prognosis (triple negative and HER2+ diseases) while 62% were with a variable prognosis (luminal disease). 30% underwent adjuvant treatment, 26% neoadjuvant treatment and 7% palliative treatment. Conclusion: the study was consistent with the literature. The screening policy must be a priority in the Federal District.
Editor: Escola Superior de Ciências da Saúde
Tipo: Artigo de Periódico</summary>
    <dc:date>2024-08-30T00:00:00Z</dc:date>
  </entry>
</feed>

